Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Glioblastoma multiforme (GBM) the most common primary brain malignancy in adults, has an approximately 25% 2-year overall survival despite improvements in both first and second-line therapies. However, options still remain limited in those patients progressing after failure of temozolomide.
Citation: Levitt D, Slim J, Slim JN, Boulmay B, Galliano G (2015) Albumin-Linked Doxorubicin (Aldoxorubicin) as Treatment for Relapsed Glioblastoma: A Case Report. J Nucl Med Radiat Ther 6:216 doi: 10.4172/2155-9619.1000216
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi